Friday, September 01, 2017 10:15 PM ET
Insider Selling in Eli Lilly (LLY) Shares Continues
There was a significant sale of shares of Eli Lilly by an insider today, as indicated in a form 4 document filed with the SEC. One insider — Lilly Endowment Inc, 10% Owner — disposed of 180,000 shares in the company having a market value of approximately $14,590,080. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 669,733 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 849,733 shares and have averaged 212,433 shares per transaction over this time period.
The level of buy/sell trading at Eli Lilly is is higher than the 112 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 111 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for Eli Lilly insiders was also higher. Within the peer group there were 3,389,986 shares purchased and 5,016,302 shares sold with company insiders selling 14,651 shares on average.
The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.